ADVFN US – Market Content Editor

  • enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates

    enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates

    enGene Holdings Inc. (NASDAQ:ENGN) shares climbed 5% on Tuesday after the clinical-stage genetic medicines company reported promising new data showing improved complete response rates for its investigational bladder cancer treatment detalimogene voraplasmid. The company said that detalimogene achieved a 62% complete response rate at six months in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer…

  • Surmodics Shares Skyrocket 50% After Court Rejects FTC Request to Block GTCR Acquisition

    Surmodics Shares Skyrocket 50% After Court Rejects FTC Request to Block GTCR Acquisition

    Surmodics Inc. (NASDAQ:SRDX) shares soared 50% on Tuesday after a U.S. District Court denied the Federal Trade Commission’s (FTC) motion for a preliminary injunction that sought to halt the company’s pending acquisition by GTCR LLC. The ruling from the Northern District of Illinois removes a major obstacle to the merger, though the deal remains subject…

  • Soleno Therapeutics Shares Jump 8% Following $100 Million Accelerated Buyback Plan

    Soleno Therapeutics Shares Jump 8% Following $100 Million Accelerated Buyback Plan

    Soleno Therapeutics (NASDAQ:SLNO) shares surged 8% on Tuesday after the biopharmaceutical company announced a $100 million accelerated share repurchase (ASR) agreement with Jefferies LLC, underscoring confidence in its financial outlook and growth prospects. The Board of Directors approved the buyback program, which includes an initial delivery of approximately 1,511,553 shares, based on Soleno’s closing price…

  • Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value

    Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value

    Neuphoria Therapeutics (NASDAQ:NEUP) shares gained 4% on Tuesday after the clinical-stage biotechnology firm announced the initiation of a strategic review aimed at maximizing shareholder value. The company, which specializes in developing therapies for neuropsychiatric disorders, said it is evaluating a range of potential options — including mergers, acquisitions, partnerships, joint ventures, and licensing agreements. To…

  • EnviroStar Shares Tick Higher as Record Revenue Balances EPS Miss

    EnviroStar Shares Tick Higher as Record Revenue Balances EPS Miss

    EnviroStar Inc. (AMEX:EVI) shares edged up 1.7% in premarket trading on Tuesday after the company posted record first-quarter revenue, which narrowly missed analyst forecasts, while earnings came in below expectations due to higher spending on technology and integration initiatives. The commercial laundry equipment distributor reported adjusted earnings of $0.11 per share, short of the $0.15…

  • AngloGold Ashanti Shares Gain Nearly 3% as Profits Surge on Soaring Gold Prices

    AngloGold Ashanti Shares Gain Nearly 3% as Profits Surge on Soaring Gold Prices

    AngloGold Ashanti plc (NYSE:AU) saw its shares climb 2.7% in premarket trading on Tuesday after the gold miner posted a record-breaking third quarter, driven by higher gold prices and strong cost management. The company reported free cash flow of $920 million, up 141% year-on-year, while headline earnings jumped to $672 million, or $1.32 per share,…

  • Sea Shares Slide Over 5% as Earnings Miss Overshadows Strong Revenue Growth

    Sea Shares Slide Over 5% as Earnings Miss Overshadows Strong Revenue Growth

    Sea Limited (NYSE:SE) shares tumbled more than 5% in premarket trading on Tuesday after the Southeast Asian technology conglomerate reported third-quarter 2025 earnings that missed forecasts, despite strong revenue expansion across all its business divisions. The company posted adjusted earnings of $0.59 per share, falling short of analysts’ expectations of $1.02 per share by 43…

  • ChipMOS Shares Jump 7% After Q3 Earnings and Revenue Beat Forecasts

    ChipMOS Shares Jump 7% After Q3 Earnings and Revenue Beat Forecasts

    ChipMOS Technologies Inc.. (NASDAQ:IMOS) shares climbed 6.8% in premarket trading on Tuesday after the company delivered third-quarter 2025 results that far exceeded analyst projections, showing solid revenue growth and a sharp rebound in profitability. The semiconductor testing and packaging specialist reported earnings per ADS of $0.33, tripling the consensus forecast of $0.11, while revenue reached…

  • Hesai Group Delivers 47.5% Revenue Surge in Q3 Amid Rising Global Lidar Demand

    Hesai Group Delivers 47.5% Revenue Surge in Q3 Amid Rising Global Lidar Demand

    Hesai Group (NASDAQ:HSAI), the world’s leading manufacturer of lidar sensors for automotive and robotics applications, reported third-quarter net revenue of 795.4 million yuan, marking a 47.5% year-on-year increase. The company said the strong performance was driven by higher sales of advanced driver-assistance systems (ADAS) for vehicles and continued momentum in robotic lidar solutions, reflecting sustained…

  • Nvidia Shares Dip After SoftBank Confirms Full Exit from AI Chip Leader

    Nvidia Shares Dip After SoftBank Confirms Full Exit from AI Chip Leader

    Shares of Nvidia (NASDAQ:NVDA) edged lower in U.S. premarket trading on Tuesday following news that SoftBank Group Corp. had sold its entire stake in the semiconductor giant, cashing out $5.83 billion amid soaring enthusiasm for artificial intelligence investments. In its quarterly earnings report, SoftBank disclosed that it sold 32.1 million Nvidia shares last month, along…